ArticleCancer immunology research2021

Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.

Jinming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.